AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 289: E608-E616, 2005. First published June 7, 2005; doi:10.1152/ajpendo.00009.2005
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
289/4/E608    most recent
00009.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granneman, J. G.
Right arrow Articles by Lu, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granneman, J. G.
Right arrow Articles by Lu, Y.

Metabolic and cellular plasticity in white adipose tissue I: effects of {beta}3-adrenergic receptor activation

James G. Granneman, Pipeng Li, Zhengxian Zhu, and Yuyan Lu

Departments of Psychiatry and Pathology, Center for Integrative Metabolic and Endocrine Research, Wayne State University School of Medicine, Detroit, Michigan

Submitted 10 January 2005 ; accepted in final form 27 May 2005

Selective agonists of {beta}3-adrenergic receptors (Adrb3) exhibit potent anti-diabetes properties in rodent models when given chronically, yet the mechanisms involved are poorly understood. A salient feature of chronic Adrb3 activation is pronounced remodeling of white adipose tissue (WAT), which includes mitochondrial biogenesis and elevation of metabolic rate. To gain insights into potential mechanisms underlying WAT remodeling, the time course of remodeling induced by the Adrb3 agonist CL-316,243 (CL) was analyzed using histological, physiological, and global gene profiling approaches. The results indicate that continuous CL treatment induced a transient proinflammatory response that was followed by cellular proliferation among stromal cells and multilocular adipoctyes. CL treatment strongly fragmented the central lipid storage droplet of mature adipocytes and induced mitochondrial biogenesis within these cells. Mitochondrial biogenesis was correlated with the upregulation of genes involved in fatty acid oxidation and mitochondrial electron transport activity. The elevated catabolic activity of WAT was temporally correlated with upregulation of peroxisome proliferator-activated receptor-{alpha} and its target genes, suggesting involvement of this transcription factor in coordinating the gene program that elevates WAT catabolic activity.



Address for reprint requests and other correspondence: J. G. Granneman, CIMER/WSU, 111 Lande Research Bldg., 550 E. Canfield, Detroit, MI 48201 (e-mail: jgranne{at}med.wayne.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. P. Mottillo, X. J. Shen, and J. G. Granneman
Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1188 - E1197.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
I. Bogacka, T. W. Gettys, L. de Jonge, T. Nguyen, J. M. Smith, H. Xie, F. Greenway, and S. R. Smith
The Effect of {beta}-Adrenergic and Peroxisome Proliferator-Activated Receptor-{gamma} Stimulation on Target Genes Related to Lipid Metabolism in Human Subcutaneous Adipose Tissue
Diabetes Care, May 1, 2007; 30(5): 1179 - 1186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Li, Z. Zhu, Y. Lu, and J. G. Granneman
Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-{alpha}
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E617 - E626.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.